18F-FDG PET/CT提取的基线肿瘤负荷与肿瘤播散参数在早期或晚期成人霍奇金淋巴瘤患者队列中的预后价值
该回顾性研究纳入166例≥18岁经典型霍奇金淋巴瘤患者,评估基线18F-FDG PET/CT参数(SUVmax、TMTV、TLG、Dmax、Dbulk)的预后价值。中位随访55个月,单因素分析仅IPS>1、TMTV>107 cm³和TLG>1628为PFS显著预后因素;多因素分析显示IPS和TLG独立预后,联合可识别4个风险组(P<0.001)。结论认为基线TLG联合IPS可改善PFS预测。
要点
- 单因素分析中IPS>1、TMTV>107 cm³和TLG>1628为PFS显著预后因素。
- 多因素分析显示IPS和TLG为独立预后因素,联合可识别4个风险组(P<0.001)。
- 4年PFS:低危组95%、中低危组79%、中高危组78%、高危组71%。
核心结论
- 基线TLG联合IPS可改善经典型霍奇金淋巴瘤患者的PFS预测。
研究设计与样本
- 回顾性纳入166例年龄≥18岁的经典型霍奇金淋巴瘤患者。
- 111例接受ABVD或ABVD样方案治疗(联合或不联合放疗),55例接受 escalated BEACOPP 方案治疗。
- 中位年龄32岁,中位随访55个月。
- 对二分化的临床生物学和PET/CT参数(SUVmax、TMTV、TLG、Dmax、Dbulk)进行PFS分析,以ROC分析约登指数最大化确定最佳截断值,采用Kaplan-Meier曲线和log-rank检验,Cox比例风险模型计算风险比。
主要发现
- 单因素分析仅IPS>1、TMTV>107 cm³和TLG>1628为PFS的显著预后因素。
- 多因素分析显示IPS和TLG为独立预后因素,联合可识别4个风险组(P<0.001)。
- 4年PFS:低危组(低TLG且低IPS)95%,中低危组(高IPS且低TLG)79%,中高危组(低IPS且高TLG)78%,高危组(高TLG且高IPS)71%。
关键数值与推荐
- IPS>1、TMTV>107 cm³和TLG>1628为单因素分析中PFS的显著预后因素。
- 多因素分析中IPS和TLG为独立预后因素,联合分组P<0.001。
- 4年PFS:低危组95%、中低危组79%、中高危组78%、高危组71%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We aimed to assess the prognostic value of baseline tumor burden and dissemination parameters extracted from 18 F-FDG PET/CT in patients with early or advanced Hodgkin lymphoma (HL) treated with ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) or escalated BEACOPP (increased bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone). PATIENTS AND METHODS: Patients aged ≥18 years with classical Hodgkin lymphoma were retrospectively included. Progression-free survival (PFS) analysis of dichotomized clinicobiological and PET/CT parameters (SUV max , TMTV, TLG, D max , and D bulk ) was performed. Optimal cutoff values for quantitative metrics were defined as the values maximizing the Youden index from receiver operating characteristic analysis. PFS rates were estimated with Kaplan-Meier curves, and the log-rank test was used to assess statistical significance. Hazard ratios were calculated using Cox proportional hazards models. RESULTS: With a median age of 32 years, 166 patients were enrolled. A total of 111 patients had ABVD or ABVD-like treatment with or without radiotherapy and 55 patients with escalated BEACOPP treatment. The median follow-up was 55 months. Only International Prognostic Score (IPS >1), TMTV >107 cm 3 , and TLG >1628 were found to be significant prognostic factors for PFS on univariate analysis. Multivariate analysis revealed that IPS and TLG were independently prognostic and, combined, identified 4 risk groups ( P < 0.001): low (low TLG and low IPS; 4-year PFS, 95%), intermediate-low (high IPS and low TLG; 4-year PFS, 79%), intermediate-high (low IPS and high TLG; 4-year PFS, 78%), and high (high TLG and high IPS; 4-year PFS, 71%). CONCLUSIONS: Combining baseline TLG with IPS could improve PFS prediction.
引用
- Mouheb M, Pierre-Jean M, Devillers A, et al. Prognostic Value of Baseline Tumor Burden and Tumor Dissemination Extracted From 18 F-FDG PET/CT in a Cohort of Adult Patients With Early or Advanced Hodgkin Lymphoma. Clin Nucl Med. 2023. PMID: 38015041. doi:10.1097/RLU.0000000000004930
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。